<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>OPERATOR_BCSC1819_S12_C14_p281-294_2P</title>
		<link href="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="OPERATOR_BCSC1819_S12_C14_p281-294_2P" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter</span><span class="cn-chap"> </span>14</p>
			<p class="chapter-title">Retinal Degenerations Associated With Systemic Disease</p>
			<p class="body-text--no-indent-">For many of the conditions discussed in this chapter, a correct diagnosis could lead to meaningful, and in some cases, life-&#173;saving therapies or interventions. This is a highly heterogeneous group of systemic diseases that often require specialty care due to potentially severe associated morbidities and mortality. Impor&#173;tant diagnostic and prognostic questions that arise in evaluating a patient who pres&#173;ents with ret&#173;i&#173;nal degeneration include the following:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-1">Is the degeneration hereditary or acquired?</li>
				<li class="bullet-list-mid ParaOverride-1">Is the condition stable or progressive?</li>
				<li class="bullet-list-mid">Can a precise diagnosis be made?</li>
			</ul>
			<p class="h1 ParaOverride-2">Retinal Degeneration With Systemic Involvement</p>
			<div id="Chapt14_Top1">
			<p class="body-text--no-indent-">Pigmentary retinopathy and ret&#173;i&#173;nal degenerations may be associated with a wide spectrum of ge&#173;ne&#173;tic or acquired diseases. The term <span class="italic">pigmentary retinopathy</span> refers broadly to a panret&#173;i&#173;nal disturbance of the ret&#173;ina and ret&#173;i&#173;nal pigment epithelium (RPE). Pigment deposits define most pigmentary retinopathies and typically pres&#173;ent in the form of pigment clumps or spicules, but some diseases have a generalized depigmentation characterized by atrophy and &#173;little or no pigment deposition. This section summarizes some impor&#173;tant examples of &#173;these disorders (<span class="xref-table">&#173;Table&#160;14-1</span>).</p>
			<p class="h2 ParaOverride-3">Infantile-&#173;Onset to Early Childhood–&#173;Onset Syndromes</p>
			<p class="body-text--no-indent-"><span class="italic">Leber congenital amaurosis</span> (LCA) should be considered in any infant suspected of poor or declining vision if a severely diminished or extinguished electroretinogram (ERG) signal is pres&#173;ent at birth (also see <span class="xref-local">Chapter&#160;13</span>). If the ERG signal is diminished and the changes are progressive, evaluation should include careful screening for congenital syndromes and metabolic disorders that affect the ret&#173;i&#173;na.</p>
			<p class="reference--journal--single">den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. Leber congenital amaurosis: genes, proteins and disease mechanisms. <span class="italic">Prog Retin Eye Res.</span> 2008:27(4):391–419.</p>
			<p class="h2 ParaOverride-3">Bardet-&#173;Biedl Syndrome</p>
			<p class="body-text--no-indent-"><span class="italic">Bardet-&#173;Biedl syndrome</span> comprises several dif&#173;fer&#173;ent diseases with a similar constellation of findings, including pigmentary retinopathy (with or without pigment deposits), obesity, polydactyly, hypogonadism, and cognitive disability. Patients with Bardet-&#173;Biedl syndrome typically demonstrate a severe but variable form of rod–&#173;cone dystrophy, usually sine pigmento, with a bull’s-&#173;eye atrophic maculopathy (<span class="xref-figure">Fig 14-1</span>). &#173;These disorders &#173;were previously classified as autosomal recessive, but molecular studies strongly suggest that many are &#173;multigenic, with 2 or even 3 dif&#173;fer&#173;ent mutations contributing to the phenotype. Increasing evidence suggests that the primary functions of the proteins affected in Bardet-&#173;Biedl syndrome are to mediate and regulate microtubule-&#173;based intracellular transport pro&#173;cesses.</p>
			<p class="reference--journal--single">M’hamdi O, Ouertani I, Chaabouni-&#173;Bouhamed&#160;H. Update on the ge&#173;ne&#173;tics of Bardet-&#173;Biedl syndrome. <span class="italic">Mol Syndromol.</span> 2014;5(2):51–56.</p>
			<p class="h2 ParaOverride-4">Hearing Loss and Pigmentary Retinopathy: Usher Syndrome</p>
			<p class="body-text--no-indent-"><span class="italic">Usher syndrome</span> is the most common name used to describe the association of retinitis pigmentosa (RP) with congenital sensorineural hearing loss, &#173;whether partial or profound. The prevalence of Usher syndrome is thought to be 3 cases per 100,000 persons. &#173;There are 3 types of Usher syndrome; patients with type 1 have early and profound deafness, RP, and vestibular areflexia. Type 2 patients are born with moderate to severe hearing loss and develop RP within their second de&#173;cade but have normal vestibular function. Type 3 patients have progressive hearing loss, variable RP, and sporadic vestibular function.</p>
			<p class="body-text">All forms show autosomal recessive inheritance. Currently, 16 ge&#173;ne&#173;tic loci have been identified as associated with Usher syndrome. The proteins encoded by &#173;these genes are part of a dynamic protein complex pres&#173;ent in the cilia of the inner ear and in the cone outer segments of the photoreceptor cells of the ret&#173;ina. Other ge&#173;ne&#173;tic conditions and environmental &#173;factors that may also lead to pigmentary retinopathy and hearing loss include Alport, Alstr<span class="accent">ö</span>m, Cockayne, and Hurler syndromes; spondyloepiphyseal dysplasia congenita; Refsum disease; and congenital rubella.</p>
			<p class="reference--journal--single">Mathur P, Yang&#160;J. Usher syndrome: hearing loss, ret&#173;i&#173;nal degeneration and associated abnormalities<span class="italic">. Biochim Biophys Acta.</span> 2015;1852(3):406–420.</p>
			<p class="h2 ParaOverride-4">Neuromuscular Disorders</p>
			<p class="body-text--no-indent-">Pigmentary retinopathy associated with neuromuscular pathology is pres&#173;ent in a variety of disorders (see &#173;Table&#160;14-1). ERG abnormalities found in &#173;these neurologic disorders confirm the presence of retinopathy but are not diagnostic for any one disorder.</p>
			<p class="body-text">Although <span class="italic">Duchenne muscular dystrophy</span> does not cause a pigmentary retinopathy, it deserves mention &#173;because the ERG signal shows a negative waveform similar to that found in patients with congenital stationary night blindness (CSNB)—&#173;specifically, a normal a-&#173;wave but a reduced b-&#173;wave (see <span class="xref-local">Chapters&#160;3</span> and <span class="xref-local">12</span>). This ERG response suggests a defective “on-&#173;response” pathway, but patients with this disorder do not have night blindness. Interestingly, Duchenne muscular dystrophy is caused by mutations in the gene for <span class="italic">dystrophin,</span> a protein that is abundant in muscle but also found in neural synaptic regions and in the ret&#173;i&#173;na.</p>
			<p class="reference--journal--single">Barboni MT, Nagy BV, de Ara<span class="accent">ú</span>jo Moura AL, et&#160;al. ON and OFF electroretinography and contrast sensitivity in Duchenne muscular dystrophy. <span class="italic">Invest Ophthalmol Vis Sci.</span> 2013;54(5):3195–3204.</p>
			<p class="h2 ParaOverride-4">Other Organ System Disorders</p>
			<p class="body-text--no-indent-">Most retinopathies associated with other organ systems are rare and ge&#173;ne&#173;tic, and clinicians may find the Online Mendelian Inheritance in Man website (<a href="www.omim.org">www.omim.org</a>) useful in recognizing them.</p>
			<p class="h3">Renal diseases</p>
			<p class="body-text--no-indent-">Several forms of congenital renal disease may be associated with ret&#173;i&#173;nal degeneration. &#173;<span class="italic">Familial juvenile nephronophthisis</span> is one of the &#173;family of renal-&#173;retinal dysplasia (and ciliopathy) characterized by autosomal recessive inheritance and childhood onset of end-&#173;stage renal disease. Individuals with Joubert syndrome have cerebellar malformation (a characteristic “molar tooth” deformity that can be observed on magnetic resonance imaging of the brain) and may also have associated chorioret&#173;i&#173;nal coloboma. Patients with Bardet-&#173;Biedl syndrome commonly have urethral reflux with pyelonephritis and kidney damage, whereas patients with Alstr<span class="accent">ö</span>m syndrome, another ret&#173;i&#173;nal ciliopathy, may demonstrate obesity, short stature, and cardiomyopathy in addition to renal disease. Jeune syndrome is a ret&#173;i&#173;nal ciliopathy that is complicated by cystic kidney disease and asphyxiating thoracic dystrophy.</p>
			<p class="h3">Liver disease</p>
			<p class="body-text--no-indent-">Patients with Alagille syndrome pres&#173;ent with hepatorenal abnormalities including cholestatic jaundice and have several characteristic ocular findings, including posterior embryotoxin and pigmentary retinopathy, that can have a peripapillary and macular predilection.</p>
			<p class="h3">Gastrointestinal disease</p>
			<p class="body-text--no-indent-"><span class="italic">Familial adenomatous polyposis</span> (FAP, also known as <span class="italic">Gardner syndrome</span>) is associated with pigmented lesions that are similar to &#173;those found in congenital hypertrophy of the RPE. However, the lesions in FAP are smaller, ovoid, more variegated, and typically multiple and bilateral. The presence of more than 4 widely spaced, small (<span class="symbol">&lt;</span>0.5-&#173;disc-&#173;diameter) lesions per eye and bilateral involvement suggest FAP. Note that congenital grouped pigmentation (“bear tracks”) is not associated with FAP. Caused by mutations in the adenomatous polyposis gene <span class="italic">(APC),</span> FAP has an autosomal dominant inheritance pattern with incomplete expression. The pigmented ret&#173;i&#173;nal lesions are an impor&#173;tant marker for identifying &#173;family members at risk of colonic polyps, which have a high malignant potential.</p>
			<p class="h3 ParaOverride-5">Dermatologic diseases</p>
			<p class="body-text--no-indent-"><span class="italic">Ichthyosis,</span> comprising abnormal scaling, dryness, and tightness of the skin, may be found in conjunction with the pigmentary retinopathy of Refsum disease and the crystalline maculopathy of Sj<span class="accent">ö</span>gren-&#173;Larsson syndrome. <span class="italic">Incontinentia pigmenti (Bloch-&#173;Sulzberger </span><span class="italic">syndrome)</span> is a rare, X-&#173;linked disorder that pres&#173;ents only in females; the mutation is lethal in males. It is characterized by streaky skin lesions and abnormalities of the teeth and central ner&#173;vous system (CNS). Ocular involvement occurs in approximately one-&#173;third of affected females and includes pigmentary abnormalities as well as peripheral ret&#173;i&#173;nal nonperfusion and neovascularization that may cause tractional and cicatricial ret&#173;i&#173;nal detachment (also see BCSC Section&#160;6, <span class="italic">Pediatric Ophthalmology and Strabismus</span>). <span class="italic">Pseudoxanthoma </span><span class="italic">elasticum</span> is associated with a “plucked-&#173;chicken” skin appearance, peripapillary angioid streaks, and a <span class="italic">peau d’orange</span> fundus appearance (see <span class="xref-local">Chapter&#160;4</span>).</p>
			<p class="reference--journal--first">Holmstr<span class="accent">ö</span>m G, Thor<span class="accent">é</span>n K. Ocular manifestations of incontinentia pigmenti. <span class="italic">Acta Ophthalmol Scand.</span> 2000;78(3):348–353.</p>
			<p class="reference--journal--last ParaOverride-6">Traboulsi EI. Ocular manifestations of familial adenomatous polyposis (Gardner syndrome). <span class="italic">Ophthalmol Clin North Am.</span> 2005;18(1):163–166.</p>
			<p class="h3 ParaOverride-5">Dental disease</p>
			<p class="body-text--no-indent-">Amelogenesis imperfecta is a ge&#173;ne&#173;tic disease that &#173;causes abnormalities in dentition development resulting from defective enamel production. When associated with a cone–&#173;rod dystrophy this condition is referred to as <span class="italic">Jalili syndrome</span> and has a wide range of clinical ret&#173;i&#173;nal manifestations, including macular coloboma and pigmentary retinopathy.</p>
			<p class="h2 ParaOverride-7">Paraneoplastic and Autoimmune Retinopathies</p>
			<p class="body-text--no-indent-">Occasionally, ret&#173;i&#173;nal degeneration is a complication of cancer resulting from a paraneoplastic immunologic mechanism. BCSC Section&#160;9, <span class="italic">Intraocular Inflammation and Uveitis,</span> explains the role of the immune system in this pro&#173;cess. The 2 main paraneoplastic retinopathy syndromes are (1) <span class="italic">cancer-&#173;associated retinopathy</span> (CAR; Fig 14-2) and (2)&#160;<span class="italic">melanoma-&#173;associated </span><span class="italic">retinopathy</span> (MAR). The characteristic ERG findings in MAR are a preserved dark adapted a-wave followed by a strikingly reduced b-wave, resulting in an electronegative ERG, which is similar to the ERG findings in CSNB. Patients with MAR usually pres&#173;ent with an acquired night blindness and shimmering photopsias.</p>
			<p class="body-text">A third entity, <span class="italic">autoimmune retinopathy,</span> refers to an acquired, presumed immunologically mediated, ret&#173;i&#173;nal degeneration that resembles paraneoplastic retinopathy but without any identifiable systemic malignancy.</p>
			<p class="body-text"><span class="italic">Bilateral diffuse uveal melanocytic proliferation</span> (BDUMP) is a paraneoplastic syndrome characterized by multiple melanocytic lesions of the choroid that may be associated with rapidly progressive posterior subcapsular cataract, iris and ciliary body cysts, and exudative ret&#173;i&#173;nal detachment. BDUMP has been associated with vari&#173;ous systemic malignancies (see <span class="xref-local">Chapter&#160;9</span>). <span class="italic">Acute exudative polymorphous vitelliform maculopathy,</span> which is characterized by multiple waxing and waning subret&#173;i&#173;nal vitelliform lesions, has been reported in association with metastatic cutaneous melanoma and other systemic malignancies.</p>
			<p class="reference--journal--first">Fox AR, Gordon LK, Heckenlively JR, et&#160;al. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. <span class="italic">Am J Ophthalmol.</span> 2016;168:183–190.</p>
			<p class="reference--journal--mid">Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. <span class="italic">Am J Ophthalmol.</span> 2014;157(2):266–272.</p>
			<p class="reference--journal--last">Rahimy E, Sarraf&#160;D. Paraneoplastic and non-&#173;paraneoplastic retinopathy and optic neuropathy: evaluation and management. <span class="italic">Surv Ophthalmol.</span> 2013;58(5);430–458.</p>
			</div>
			<p class="h1">Metabolic Diseases</p>
			<div id="Chapt14_Top2">
			<p class="body-text--no-indent-">When evaluating patients with ret&#173;i&#173;nal degeneration, it is impor&#173;tant to consider metabolic diseases. Some disorders, such as albinism and conditions associated with CNS abnormalities, are covered in BCSC Section&#160;6, <span class="italic">Pediatric Ophthalmology and Strabismus.</span> Other metabolic disorders, such as abetalipoproteinemia and Refsum disease, are among the differential diagnostic concerns for RP, even though the retinopathy associated with &#173;these disorders may be granular and aty&#173;pi&#173;cal.</p>
			<p class="h2">Albinism</p>
			<p class="body-text--no-indent-">In albinism, the synthesis of melanin is reduced or absent. When the reduction in melanin biosynthesis affects the eyes, skin, and hair follicles, the disease is called <span class="italic">oculocutaneous </span><span class="italic">albinism.</span> &#173;These disorders usually have an autosomal recessive inheritance pattern. If the skin and hair appear normally pigmented and only ocular pigmentation is affected, the condition is called <span class="italic">ocular albinism.</span> Ocular albinism typically has an X-&#173;linked inheritance pattern. Female carriers of X-&#173;linked ocular albinism may show partial iris transillumination and fundus pigment mosaicism.</p>
			<p class="body-text">Regardless of the type of albinism, ocular involvement generally conforms to 1 of 2 clinical patterns: (1) congenitally subnormal visual acuity (typically 20/100–20/400) and nystagmus or (2) normal or minimally reduced visual acuity without nystagmus. The first pattern is true albinism; the second has been termed <span class="italic">albinoidism</span> &#173;because of its milder visual consequences. Both patterns share the clinical features of photophobia, iris transillumination, and hypopigmented fundi. They differ according to &#173;whether or not the fovea develops normally; in true albinism, the fovea is hypoplastic, with no foveal pit or reflex and no evident luteal pigment (<span class="xref-figure">Fig 14-3</span>). The gold standard for diagnosis of true albinism is the finding of characteristic abnormalities of the flash and pattern visual evoked potentials (VEPs). Compared with a normal symmetric response, in albinism, a single eye stimulation &#173;will result in an asymmetric occipital response &#173;because &#173;there is a greater number of decussating fibers.</p>
			<p class="body-text">Oculocutaneous albinism has 2 forms with potentially lethal systemic implications. The first, <span class="italic">C</span><span class="italic">h</span><span class="accent_italic">é</span><span class="italic">diak-&#173;Higashi syndrome,</span> combines albinism with neutropenia and an extreme susceptibility to infections as well as other complications such as bleeding (caused by deficient platelets). The second, <span class="italic">Hermansky-&#173;Pudlak syndrome,</span> is characterized by a platelet defect that &#173;causes easy bruising and bleeding. In the United States, most patients with Hermansky-&#173;Pudlak syndrome are of Puerto Rican descent.</p>
			<p class="reference--non-journal--single">King RA, Jackson IJ, Oetting WS. &#173;Human albinism and mouse models. In: Wright AF, Jay B, eds. <span class="italic">Molecular Ge&#173;ne&#173;tics of Inherited Eye Disorders.</span> Chur, Switzerland: Harwood Academic; 1994:89–122.</p>
			<p class="h2">Central Ner&#173;vous System Metabolic Abnormalities</p>
			<p class="body-text--no-indent-">Although a comprehensive description is beyond the scope of this chapter, the following discussion includes some of the major inherited metabolic diseases known to affect the CNS and ret&#173;ina (see &#173;Table&#160;14-1). See BCSC Section&#160;6, <span class="italic">Pediatric Ophthalmology and Strabismus,</span> for a listing of the ocular findings in inborn errors of metabolism.</p>
			<p class="h3">Neuronal ceroid lipofuscinoses</p>
			<p class="body-text--no-indent-">The neuronal ceroid lipofuscinoses (NCLs) are a group of autosomal recessive diseases caused by the accumulation of waxy lipopigments (eg, ceroid and lipofuscin) within the lysosomes of neurons and other cells. &#173;These disorders usually become evident in early childhood and are characterized by progressive dementia, seizures, and loss of vision associated with a pigmentary retinopathy in early-&#173;onset cases. A diagnosis can be made with ge&#173;ne&#173;tic testing, in addition to a peripheral blood smear or biopsy of conjunctival or other tissues looking for the characteristic curvilinear, fingerprint-&#173;like or granular inclusions on electron microscopy. The infantile and juvenile types of NCLs are associated with pigmentary retinopathies (see &#173;Table&#160;14-1). Ocular findings in infantile NCL include optic atrophy; macular pigmentary changes including bull’s-&#173;eye atrophic maculopathy, mottling of the fundus periphery, and ret&#173;i&#173;nal vascular attenuation; and reduced or absent ERG signals (<span class="xref-figure">Fig </span><span class="xref-figure">14-4</span>). The 2 adult forms of NCL do not have ocular manifestations.</p>
			<p class="h3">Abetalipoproteinemia and vitamin A deficiency</p>
			<p class="body-text--no-indent-">Abetalipoproteinemia is an autosomal recessive disorder in which apolipoprotein B is not synthesized, which &#173;causes fat malabsorption, fat-&#173;soluble vitamin deficiencies, and ret&#173;i&#173;nal and spinocerebellar degeneration. Supplementation with vitamins A and E is needed to prevent or ameliorate the ret&#173;i&#173;nal degeneration. The most common form of vitamin A deficiency retinopathy occurs in patients who have under&#173;gone gastric bypass surgery for obesity or small-&#173;bowel resection for Crohn disease. &#173;These patients have malabsorption of fat-&#173;soluble vitamins and may develop a blind loop syndrome, in which an overgrowth of bacteria consumes vitamin A. Patients experience nyctalopia, and if the condition remains untreated, eventually demonstrate vision loss and diffuse, drusenlike spots similar to &#173;those observed in retinitis punctata albescens.</p>
			<p class="h3">Peroxisomal disorders and Refsum disease</p>
			<p class="body-text--no-indent-">The peroxisomal disorders are mostly autosomal recessive diseases caused by the dysfunction or absence of peroxisomes or peroxisomal enzymes, which leads to defective oxidation and accumulation of very-&#173;long-&#173;chain fatty acids. <span class="italic">Zellweger syndrome</span> is the prototype of peroxisomal diseases. Severe infantile-&#173;onset ret&#173;i&#173;nal degeneration is associated with hypotonia, psychomotor impairment, seizures, characteristic facies, renal cysts, and hepatic interstitial fibrosis. Death usually occurs in infancy. Patients with <span class="italic">neonatal adrenoleuko</span><span class="italic">dystrophy</span> also pres&#173;ent in infancy but generally survive &#173;until the age of 7–10&#160;years (<span class="xref-figure">Fig 14-5</span>).</p>
			<p class="body-text">Similar but less severe findings are pres&#173;ent in <span class="italic">infantile Refsum disease,</span> which is characterized by pigmentary retinopathy with reduced or extinguished ERG signals, cerebellar ataxia, polyneuropathy, anosmia, hearing loss, and cardiomyopathy. Diagnosis is made by demonstrating elevated plasma levels of phytanic acid or reduced phytanic acid oxidase activity in cultured fibroblasts. Dietary restriction of phytanic acid precursors may slow or stabilize the neuropathy but typically not the ret&#173;i&#173;nal degeneration.</p>
			<p class="h3">Mucopolysaccharidoses</p>
			<p class="body-text--no-indent-">The systemic <span class="italic">mucopolysaccharidoses</span> (MPSs) are caused by inherited defects in catabolic &#173;lysosomal enzymes that degrade the glycosaminoglycans dermatan sulfate, keratan sulfate, and heparan sulfate. The MPSs are transmitted as autosomal recessive traits except for type II, which is an X-&#173;linked recessive disorder (see &#173;Table&#160;14-1).</p>
			<p class="body-text">Only &#173;those MPSs in which heparan sulfate is stored are associated with ret&#173;i&#173;nal dystrophy. &#173;These include MPS type I H <span class="italic">(Hurler syndrome)</span> and MPS type I S <span class="italic">(Scheie syn</span><span class="italic">drome),</span> the clinical features of which include coarse facies, cognitive disabilities, corneal clouding, and ret&#173;i&#173;nal degeneration. The ret&#173;i&#173;nal pigmentary changes may be subtle, but the ERG response is abnormal. MPS type II <span class="italic">(Hunter syndrome)</span> also features pigmentary retinopathy but corneal clouding, if pres&#173;ent, is only mild; patients have coarse facies and short stature and may show cognitive disabilities. In MPS type III <span class="italic">(Sanfilippo syndrome),</span> somatic stigmata are mild, but pigmentary retinopathy is severe.</p>
			<p class="h3">Other lysosomal metabolic disorders</p>
			<p class="body-text--no-indent-"><span class="italic">Tay-&#173;Sachs disease</span> (GM<span class="subscript CharOverride-1">2</span> gangliosidosis type I), caused by a deficient subunit A of hexosaminidase A, is the most common ganglioside storage disease. Glycolipid accumulation in the brain and ret&#173;ina &#173;causes cognitive disability and blindness, and death generally occurs between the ages of 2 and 5&#160;years. Ganglion cells surrounding the fovea become filled with ganglioside and appear grayish or white, causing a cherry-&#173;red spot (<span class="xref-figure">Fig 14-6</span>).</p>
			<p class="body-text">The chronic nonneuronopathic adult form of <span class="italic">Gaucher disease</span> does not have ce&#173;re&#173;bral involvement. This disease is characterized by large accumulations of glucosylceramide in the liver, spleen, lymph nodes, skin, and bone marrow. Some patients have a cherry-&#173;red spot; &#173;others show whitish superficial lesions in the midperiphery of the fundus. Spectral-&#173;domain optical coherence tomography (SD-&#173;OCT) analy&#173;sis demonstrates multiple characteristic hyperreflective lesions located along the ret&#173;i&#173;nal surface.</p>
			<p class="body-text">The vari&#173;ous types of <span class="italic">Niemann-&#173;Pick disease</span> are caused by the absence of dif&#173;fer&#173;ent sphingomyelinase isoenzymes. Type A (acute neuronopathic) Niemann-&#173;Pick disease shows a cherry-&#173;red spot in about 50% of cases. Type B (chronic) Niemann-&#173;Pick disease, also known as <span class="italic">sea-&#173;blue histiocyte syndrome,</span> is the mildest, and although &#173;there is no functional involvement of the CNS, patients have a macular halo that is considered diagnostic (<span class="xref-figure">Fig 14-7</span>).</p>
			<p class="body-text"><span class="italic">Fabry disease</span> (angiokeratoma corporis diffusum) is an X-&#173;linked condition caused by mutations in the gene encoding alpha-&#173;galactosidase A. Ceramide trihexoside accumulates in the smooth muscle of blood vessels in the kidneys, skin, gastrointestinal tract, CNS, heart, and reticuloendothelial system. Ocular signs include corneal verticillata (whorls), tortuous conjunctival vessels, tortuous and dilated ret&#173;i&#173;nal vessels, and lens changes. Tortuosity of conjunctival and ret&#173;i&#173;nal vessels is also characteristic of fucosidosis, a rare lysosomal storage disorder caused by buildup of complex sugars due to reduced or absent activity of the alpha-&#173;<span class="SC">l</span>-&#173;fucosidase enzyme.</p>
			<p class="reference--journal--first">Gregory-&#173;Evans K, Pennesi ME, Weleber RG. Retinitis pigmentosa and allied disorders. In: Schachat AP, Wilkinson CP, Hinton DR, Sadda SR, Wiedemann P, eds. <span class="italic">Ryan’s Ret&#173;i&#173;na.</span> 6th&#160;ed. Philadelphia: Elsevier/Saunders; 2018:861–935.</p>
			<p class="reference--journal--mid">Haltia&#160;M. The neuronal ceroid-&#173;lipofuscinoses: from past to pres&#173;ent. <span class="italic">Biochim Biophys Acta.</span> 2006;1762(10):850–856.</p>
			<p class="h2">Amino Acid Disorders</p>
			<p class="body-text--no-indent-">In <span class="italic">cystinosis,</span> intralysosomal cystine accumulates &#173;because of a deficiency in the carrier protein cystinosin that typically transports it out of lysosomes. Three types are recognized, all autosomal recessive: (1) nephropathic, (2) late-&#173;onset (or intermediate), and (3) benign. Cystine crystals accumulate in the cornea and conjunctiva in all 3 types, but retinopathy develops only in patients with the nephropathic type who pres&#173;ent early (8 to 15 months of age) with progressive renal failure, growth delays, renal rickets, and hypothyroidism. The retinopathy is characterized by areas of patchy depigmentation of the RPE alternating with irregularly distributed pigment clumps and associated fine ret&#173;i&#173;nal crystals, but no significant visual disturbance. Treatment with cysteamine may be beneficial. Bietti crystalline dystrophy may also cause crystalline keratopathy and retinopathy associated with patchy loss of the choriocapillaris and RPE and with associated photoreceptor loss.</p>
			<p class="h2">Mitochondrial Disorders</p>
			<p class="body-text--no-indent-"><span class="italic">Chronic progressive external ophthalmoplegia</span> (CPEO) belongs to a group of diseases collectively termed <span class="italic">mitochondrial myopathies </span>(Fig 14-8), in which mitochondria are abnormally &#173;shaped and increased in number. Muscle biopsy specimens may reveal ragged red fibers. In addition to CPEO, the syndrome is associated with aty&#173;pi&#173;cal RP and vari&#173;ous systemic abnormalities. When associated with cardiomyopathy and cardiac conduction defects (heart block), the disorder is known as <span class="italic">Kearns-&#173;Sayre syndrome;</span> onset is usually before the age of 10&#160;years. The severity of the pigmentary retinopathy is highly variable. Many patients retain good visual function and a normal ERG signal. Other mitochondrial myopathies with pigmentary retinopathy include <span class="italic">MIDD</span> (<span class="italic">m</span>aternally <span class="italic">i</span>nherited <span class="italic">d</span>iabetes and <span class="italic">d</span>eafness; <span class="xref-figure">Fig 14-9</span>), <span class="italic">MELAS</span> (<span class="italic">m</span>itochondrial <span class="italic">e</span>ncephalomyopathy, <span class="italic">l</span>actic <span class="italic">a</span>cidosis, and <span class="italic">s</span>troke), and <span class="italic">NARP</span> (<span class="italic">n</span>eurogenic muscle weakness, <span class="italic">a</span>taxia, and <span class="italic">r</span>etinitis <span class="italic">p</span>igmentosa) syndromes.</p>
		</div>
		</div>
		<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
		</div>
		<div id="_idContainer002" class="Basic-Text-Frame">
			<table id="table001" class="No-Table-Style">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-4">
						<td class="No-Table-Style _1-BCSC-table-title-" colspan="3">
							<p class="table-title"><span class="table-number">&#173;Table&#160;14-1</span> Selected Systemic Diseases With Pigmentary Retinopathies</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style table-column-head CellOverride-1">
							<p class="table-column-head">Disorder</p>
						</td>
						<td class="No-Table-Style table-column-head CellOverride-1" />
						<td class="No-Table-Style table-column-head CellOverride-1">
							<p class="table-column-head">Features</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style _6-BCSC-table-body-head CellOverride-2 _idGenCellOverride-1" colspan="3">
							<p class="table-head">Autosomal dominant disorders</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-3">
							<p class="table-body">Arteriohepatic dysplasia (Alagille syndrome)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-3" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-3">
							<p class="table-body">Intrahepatic cholestatic syndrome, posterior embryotoxon, Axenfeld anomaly, congenital heart disease, flattened facies and bridge of nose, bony abnormalities, myopia, pigmentary retinopathy</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Charcot-&#173;Marie-&#173;Tooth disease</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Pigmentary retinopathy, degeneration of lateral horn of spinal cord, optic atrophy</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Myotonic dystrophy (Steinert disease)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Muscle wasting, “Christmas tree” cataract, ret&#173;i&#173;nal degeneration, pattern dystrophy or reticular degeneration; ERG response subnormal to abnormal</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Oculodentodigital dysplasia syndrome</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Thin nose with hypoplastic alae, narrow nostrils, abnormality of fourth and fifth fin&#173;gers, hypoplastic dental enamel, congenital cataract, colobomas</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Olivopontocerebellar atrophy</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Ret&#173;i&#173;nal degeneration (peripheral and/or macular), cerebellar ataxia, pos&#173;si&#173;ble external ophthalmoplegia</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-9">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Stickler syndrome (arthro-&#173;ophthalmopathy)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Progressive myopia with myopic ret&#173;i&#173;nal degeneration, arthropathy including joint hypermobility and arthritis, midfacial hypoplasia, high arched or cleft palate, bifid uvula; ret&#173;i&#173;nal detachment common; ERG response subnormal to abnormal</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Waardenburg syndrome</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Hypertelorism, wide bridge of nose, cochlear deafness, white forelock, heterochromia iridis, poliosis, pigment disturbance of RPE, choroidal vitiligo; ERG response normal to subnormal</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-9">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Wagner hereditary vitreoret&#173;i&#173;nal degeneration</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Narrowed and sheathed ret&#173;i&#173;nal vessels, pigmented spots in the ret&#173;i&#173;nal periphery and along ret&#173;i&#173;nal vessels, choroidal atrophy and optic atrophy, extensive liquefaction and membranous condensation of vitreous body; subnormal ERG response; overlapping features with Stickler syndrome</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-4">
						<td class="No-Table-Style _6-BCSC-table-body-head">
							<p class="table-head">Autosomal recessive disorders</p>
						</td>
						<td class="No-Table-Style _6-BCSC-table-body-head" />
						<td class="No-Table-Style _6-BCSC-table-body-head" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-10">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-5">
							<p class="table-body">Bardet-&#173;Biedl syndrome</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-5" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-5">
							<p class="table-body">Pigmentary retinopathy, bull’s-&#173;eye maculopathy, mild cognitive disabilities, polydactyly, obesity, hypogenitalism, progressive visual field loss; ERG response severely diminished to undetectable</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Bietti crystalline dystrophy</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Yellow-&#173;white crystals scattered in posterior pole, round subret&#173;i&#173;nal pigment deposits, confluent loss of RPE and choriocapillaris on fluorescein angiogram, pos&#173;si&#173;ble crystals in limbal cornea</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Spinocerebellar degeneration</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Ataxia, limb incoordination, nerve deafness, maculopathy, ret&#173;i&#173;nal degeneration, optic atrophy</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Homocystinuria</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Fine pigmentary or cystic degeneration of ret&#173;ina, marfanoid appearance, myopia, lens subluxation or dislocation, cardiovascular abnormalities (thromboses), glaucoma, cognitive disabilities</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Mannosidosis</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Macroglossia, flat nose, large head and ears, skeletal abnormalities, pos&#173;si&#173;ble hepatosplenomegaly, storage material in ret&#173;i&#173;na; resembles Hurler syndrome</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Mucopolysaccharidosis type I H (Hurler syndrome)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Early corneal clouding, gargoyle facies, deafness, cognitive disabilities, dwarfism, skeletal abnormalities, hepatosplenomegaly, optic atrophy; subnormal ERG response</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-6">
							<p class="table-body">Mucopolysaccharidosis type I S (Scheie syndrome)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-6" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-6">
							<p class="table-body">Coarse facies, aortic regurgitation, stiff joints, early clouding of the cornea, normal life span, normal intellect, pigmentary retinopathy</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-11">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-7 _idGenCellOverride-2">
							<p class="table-body">Mucopolysaccharidosis type III (Sanfilippo syndrome)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-7 _idGenCellOverride-2" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-7 _idGenCellOverride-2">
							<p class="table-body">Milder somatic stigmata than in Hurler syndrome, but severe pigmentary retinopathy</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style table-column-head CellOverride-8" />
						<td class="No-Table-Style table-column-head CellOverride-8" />
						<td class="No-Table-Style table-column-head CellOverride-8" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style table-column-head CellOverride-9" />
						<td class="No-Table-Style table-column-head CellOverride-9" />
						<td class="No-Table-Style table-column-head CellOverride-9" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style table-column-head CellOverride-10">
							<p class="table-column-head">Disorder</p>
						</td>
						<td class="No-Table-Style table-column-head CellOverride-10" />
						<td class="No-Table-Style table-column-head CellOverride-10">
							<p class="table-column-head">Features</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-12">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Neonatal adrenoleukodystrophy</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-2" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Pigmentary retinopathy, optic atrophy, seizures, hypotonia, adrenal cortical atrophy, psychomotor impairment; extinguished ERG response</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-13">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Neuronal ceroid lipofuscinoses (Batten disease)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body ParaOverride-9">Haltia-&#173;Santavuori, onset 8–18 months with rapid deterioration, fine granular inclusions <br />Jansky-&#173;Bielschowsky, onset 2–4&#160;years, rapid CNS deterioration, curvilinear body inclusions <br />Lake-&#173;Cavanagh, onset 4–6&#160;years, ataxia, dementia, curvilinear and fingerprint inclusions <br />Spielmeyer-&#173;Vogt-&#173;Batten, onset 6–8&#160;years, slowly progressive, fingerprint inclusions, bull’s-&#173;eye maculopathy</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Refsum disease</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Elevations of phytanic acid, pigmentary retinopathy, optic atrophy, partial deafness, cerebellar ataxia, ichthyosis</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Usher syndrome</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-4">
							<p class="table-body">Congenital deafness (profound or partial), pigmentary retinopathy, vestibular areflexia</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Zellweger (cerebrohepatorenal) syndrome</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Muscular hypotonia, high forehead and hypertelorism, hepatomegaly, deficient ce&#173;re&#173;bral myelination, nystagmus, cataract, microphthalmia, ret&#173;i&#173;nal degeneration; undetectable ERG response</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-4">
						<td class="No-Table-Style _6-BCSC-table-body-head CellOverride-1 _idGenCellOverride-1" colspan="3">
							<p class="table-head">X-&#173;linked pigmentary retinopathies</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-10">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-5">
							<p class="table-body">Incontinentia pigmenti (Bloch-&#173;Sulzberger syndrome)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-5" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-5">
							<p class="table-body">Skin pigmentation in lines and whorls, alopecia, dental anomalies, optic atrophy, falciform folds, cataract, nystagmus, strabismus, patchy mottling of fundi, conjunctival pigmentation</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-13">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Mucopolysaccharidosis type II (Hunter syndrome)</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Minimal or no corneal clouding, mild clinical course; onset of signs at age 2–4&#160;years: full lips, large rounded cheeks, broad nose, enlarged tongue (macroglossia), cognitive disabilities, pigmentary retinopathy; subnormal ERG response; over time, voice changes from vocal cord enlargement; pos&#173;si&#173;ble airway obstruction from airway narrowing</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Pelizaeus-&#173;Merzbacher disease</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Infantile progressive leukodystrophy, cerebellar ataxia, limb spasticity, cognitive impairment, pos&#173;si&#173;ble pigmentary retinopathy with absent foveal reflex</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-4">
						<td class="No-Table-Style _6-BCSC-table-body-head">
							<p class="table-head">Mitochondrial disorders</p>
						</td>
						<td class="No-Table-Style _6-BCSC-table-body-head" />
						<td class="No-Table-Style _6-BCSC-table-body-head" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-14">
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-5">
							<p class="table-body">Kearns-&#173;Sayre syndrome; maternally inherited diabetes and deafness (MIDD); mitochondrial encephalopathy, lactic acidosis, strokelike episodes (MELAS)</p>
						</td>
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-5" />
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-5">
							<p class="table-body">Progressive external ophthalmoplegia, ptosis, pigmentary retinopathy and/or macular atrophy, heart block (Kearns-&#173;Sayre syndrome); normal to abnormal ERG response</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-15">
						<td class="No-Table-Style _8-BCSC-table-note" colspan="3">
							<p class="table-footnote ParaOverride-10">CNS <span class="table-footnote-symbol">=</span> central ner&#173;vous system; ERG <span class="table-footnote-symbol">=</span> electroretinogram; RPE <span class="table-footnote-symbol">=</span> ret&#173;i&#173;nal pigment epithelium.</p>
							<p class="table-footnote ParaOverride-11">Data from Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. <span class="table-footnote-italic">Emery and Rimoin’s Princi&#173;ples and Practice of Medical Ge&#173;ne&#173;tics</span>. 3 vols. 4th&#160;ed. New York: Churchill Livingstone; 2002:chap 137.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer003" class=" _idGenObjectLayout-2 _idGenObjectStyleOverride-1">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006">
				<div id="_idContainer004" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/KIN00841.png" alt="" />
				</div>
				<div id="_idContainer005" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;14-1</span> Bardet-&#173;Biedl syndrome. <span class="figure-caption-bold">A, B,</span> Color fundus photo&#173;graphs show pigmentary alterations in the periphery and macula. <span class="figure-caption-bold">C,</span> Color fundus photo&#173;graph of the sibling of the patient in <span class="figure-caption-bold">(A)</span> and <span class="figure-caption-bold">(B)</span> demonstrates similar macular changes. <span class="figure-caption-bold">D,</span> Clinical photo&#173;graph of a patient’s foot with 6 toes (polydactyly). <span class="figure-source-note">(Courtesy of David Sarraf, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer007" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhr"><span class="rh-chap-num CharOverride-2">Chapter 14: </span>Ret&#173;i&#173;nal Degenerations Associated With Systemic Disease <span class="rh-bullet">●</span>  </p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer008" class="Basic-Text-Frame">
			</div>
		</div>
		<div id="_idContainer009" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhr"><span class="rh-chap-num CharOverride-2">Chapter 14: </span>Ret&#173;i&#173;nal Degenerations Associated With Systemic Disease <span class="rh-bullet">●</span>  </p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer012">
				<div id="_idContainer010" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/KIN00938.png" alt="" />
				</div>
				<div id="_idContainer011" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;14-2</span> Cancer-&#173;associated retinopathy (CAR). <span class="figure-caption-bold">A,</span> Color fundus photo&#173;graph of CAR in a patient with ovarian carcinoma. Note the severe vascular attenuation without obvious pigmentary alterations. <span class="figure-caption-bold">B,</span> Fourier-&#173;domain cross-&#173;sectional optical coherence tomography (OCT) of an eye with CAR that shows hyperreflectivity <span class="figure-caption-italic">(asterisk)</span> and disruption <span class="figure-caption-italic">(arrowheads)</span> of the outer nuclear layer external limiting membrane as well as decreases in reflectivity of the inner &#173;segment ellipsoid zone <span class="figure-caption-italic">(arrows). </span><span class="figure-source-note">(Part A courtesy of John&#160;R. Heckenlively, MD; part B used with permission </span><span class="figure-source-note">from Mesiwala NK, Shemonski N, Sandrian MG, et&#160;al. Ret&#173;i&#173;nal imaging with </span><span class="figure-source-note">en face and cross-&#173;sectional optical coher&#173;</span><span class="figure-source-note">ence </span><span class="figure-source-note">tomography delineates outer ret&#173;i&#173;nal changes in </span><span class="figure-source-note">cance</span><span class="figure-source-note">r</span><span class="figure-source-note">-&#173;associated retinopathy secondary to Merkel cell carcinoma. </span><span class="figure-source-note--rom-">J&#160;</span><span class="figure-source-note--rom-">Ophthalmic Inflamm Infect.</span><span class="figure-source-note"> 2015;5(1):53.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer013" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhr"><span class="rh-chap-num CharOverride-2">Chapter 14: </span>Ret&#173;i&#173;nal Degenerations Associated With Systemic Disease <span class="rh-bullet">●</span>  </p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer016">
				<div id="_idContainer014" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/KIN00939.png" alt="" />
				</div>
				<div id="_idContainer015" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 14-3</span> Albinism. <span class="figure-caption-bold">A,</span>&#160;Color fundus photograph shows generalized fundus hypopigmentation. <span class="figure-caption-bold">B,</span>&#160;High-magnification color fundus photograph shows foveal hypoplasia. No foveal reflex or luteal pigment is evident. <span class="figure-caption-bold">C,</span>&#160;SD-OCT image shows the lack of a foveal pit. Eccentric fixation was also present, resulting in superior decentration of the scans. <span class="figure-source-note">(Parts</span><span class="CharOverride-3">&#160;</span><span class="figure-source-note">A, B courtesy of Carl&#160;D. Regillo, MD; part&#160;C courtesy of David Browning, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer019">
				<div id="_idContainer017" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;14-4</span> Color fundus photo&#173;graph from a patient with Batten disease (juvenile neuronal ceroid lipofuscinosis) shows vascular attenuation and central ret&#173;i&#173;nal atrophy with mottled pigmentation and a wrinkled, cellophane-&#173;like surface. <span class="figure-source-note">(Used with permission from Hansen</span><span class="figure-source-note">&#160;</span><span class="figure-source-note">MS, </span><span class="figure-source-note">Hove</span><span class="figure-source-note">&#160;</span><span class="figure-source-note">MN, Jensen H, Larsen&#160;M. Optical coherence tomography in juvenile neuronal ceroid lipo</span><span class="figure-source-note">fuscinosis. </span><span class="figure-source-note--rom-">Retin Cases Brief Rep.</span><span class="figure-source-note"> 2016;10(2):137–139.)</span></p>
				</div>
				<div id="_idContainer018" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/AAX-10105.jpg" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer020" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhr"><span class="rh-chap-num CharOverride-2">Chapter 14: </span>Ret&#173;i&#173;nal Degenerations Associated With Systemic Disease <span class="rh-bullet">●</span>  </p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer023">
				<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/AAX-0535.png" alt="" />
				</div>
				<div id="_idContainer022" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;14-5</span> Neonatal adrenoleukodystrophy. Color fundus photo&#173;graph shows ret&#173;i&#173;nal arte&#173;riolar attenuation, diffuse pigmentary alterations, and mild optic atrophy. <span class="figure-source-note">(Courtesy of Mark&#160;W. &#173;Johnson, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer026">
				<div id="_idContainer024" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/AAX-0537.png" alt="" />
				</div>
				<div id="_idContainer025" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-12"><span class="figure-number">Figure&#160;14-6</span> Tay-&#173;Sachs disease. Color fundus photo&#173;graph shows a cherry-&#173;red spot.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer029">
				<div id="_idContainer027" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;14-7</span> Chronic Niemann-&#173;Pick disease. Color fundus photo&#173;graph shows a macular halo. <span class="figure-source-note">(Courtesy of Mark&#160;W. Johnson, MD.)</span></p>
				</div>
				<div id="_idContainer028" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/AAX-0538.png" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer030" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhr"><span class="rh-chap-num CharOverride-2">Chapter 14: </span>Ret&#173;i&#173;nal Degenerations Associated With Systemic Disease <span class="rh-bullet">●</span>  </p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer033">
				<div id="_idContainer031" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/KIN00842.png" alt="" />
				</div>
				<div id="_idContainer032" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;14-8</span> Chronic progressive external ophthalmoplegia (CPEO) and mitochondrial associated retinopathy. <span class="figure-caption-bold">A,</span> Color fundus photo&#173;graph shows diffuse ret&#173;i&#173;nal pigment epithelial mottling. <span class="figure-caption-bold">B,</span> Corresponding mottled hyper-&#173; and hypofluorescence in the arteriovenous-&#173;phase fluorescein angiography image. <span class="figure-caption-bold">C,</span> Color photo&#173;graph shows bilateral ptotic eyelids and eyes in a misaligned exotropic position from poor extraocular muscle function consistent with CPEO caused by a mitochondrial mutation. <span class="figure-source-note">(Courtesy of David Sarraf, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer034" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet">●</span> Retina and Vitreous</p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer035" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="OPERATOR_BCSC1819_S12_C14_p281-294_2P-web-resources/image/KIN00843.png" alt="" />
			</div>
		</div>
		<div id="_idContainer036" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure&#160;14-9</span> Maternally inherited diabetes and deafness (MIDD). Color fundus photo&#173;graph <span class="figure-caption-bold">(</span><span class="figure-caption-bold">A),</span>&#160;late fluorescein angiography frame <span class="figure-caption-bold">(B),</span>&#160;and fundus autofluorescence image <span class="figure-caption-bold">(C)</span>&#160;show retinal pigment epithelial atrophy in a perifoveal distribution in a patient with MIDD caused by a mitochondrial mutation. &#173;These findings &#173;were all symmetrically pres&#173;ent in the fellow eye. <span class="figure-source-note">(Courtesy </span><span class="figure-source-note">of Herb Cantrill, MD.)</span></p>
		</div>
	</body>
</html>
